CC
NVAX icon

Centiva Capital’s Novavax NVAX Stock Holding History

Centiva Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,959
Closed -$96.2K – 1994
2024
Q4 		$96.2K Buy
+11,959
New +$115K ﹤0.01% 1498
2023
Q1 		– Sell
-67
Closed -$689 – 1772
2022
Q4 		$689 Sell
67
-41,686
-100% -$736K ﹤0.01% 1324
2022
Q3 		$760K Sell
41,753
-6,344
-13% -$275K 0.06% 731
2022
Q2 		$2.47M Buy
48,097
+7,487
+18% +$388K 0.14% 308
2022
Q1 		$2.99M Buy
40,610
+14,632
+56% +$1.3M 0.17% 302
2021
Q4 		$3.72M Buy
25,978
+13,477
+108% +$2.32M 0.24% 232
2021
Q3 		$2.59M Buy
12,501
+291
+2% +$64.1K 0.21% 133
2021
Q2 		$2.59M Buy
12,210
+10,940
+861% +$2M 0.2% 266
2021
Q1 		$230K Buy
+1,270
New +$253K 0.03% 917

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.13B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return